A04878 | Pages: 247 | Sep 2020 | 27239 Views | ||
Author(s) : Sanjivan Gill , Onkar Sumant | Tables: 122 | Charts: 53 |
|
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Genetic Testing Market
Request Now !The genetic testing market accounted for $ 12,682 million in 2019, and is expected to reach $ 21,260 million by 2027, registering a CAGR of 10.1% from 2020 to 2027.
Predictive & presymptomatic testing segment is expected to witness a decline as genetic counselors are largely unable to see patients in person, doctors are not available for counselling and laboratories are not able to run the tests due to COVID-19 pandemic.
Genetic tests are defined as medical devices available in the form of kits and panels that are used for testing genetic diseases in humans. Furthermore, the testing is performed by collecting samples of blood from patients. These samples are then run on laboratory machines using test kits. In addition, there are different types of tests used in testing of genetic disorders. For instance, some genetic tests include, predictive & presymptomatic testing, carrier testing, prenatal & newborn testing, diagnostic testing, pharmacogenomic testing, and others. In addition, these tests are used in diagnosis of medical conditions such as cancer diagnosis, genetic disease diagnosis, and cardiovascular disease diagnosis.
Get more information on this report : Request Sample Pages
The global genetic testing market is expected to register substantial growth in the future, owing to rise in incidences of genetic disorders and cancer and rise in awareness & acceptance of personalized medicines. For instance, genetic testing has been widely used in pharmacogenomics, also referred as drug-gene testing. In addition, advancements in genetic testing techniques are expected to boost the genetic testing market growth during the forecast period. However, standardization concerns of genetic testing-based diagnostics and stringent regulatory requirements for product approvals are anticipated to hamper the genetic testing market growth during the forecast period. Conversely, untapped emerging markets in developing countries are expected to provide remunerative opportunities for the market players. For instance, Healthcare systems in developing countries such as Brazil, India, and China have experienced significant increase in investments in healthcare and infrastructure, which leads to surge in demand for genetic testing in the region.
COVID-19 pandemic has also affected the market adversely. For instance, after COVID-19 was declared as a pandemic by the WHO, countries worldwide adopted lockdowns to observe social distancing as a measure to contain the spread. This led to disruption, limitation, challenges, and changes in each sector of every industry. Similarly, the pandemic has a negative effect on the genetic testing market. This is attributed to the fact that genetic counselors are largely unable to see patients in person, doctors are not available for counselling, and laboratories are not able to run the tests. In addition, governmental bodies such as Centers for Medicaid Services (CMS) presently do not recognize genetic counsellors as healthcare providers and hence, they are not exempted from practicing during lockdowns. Furthermore, clinics reduced face to face genetic counselling to help prevent the spread. However, genetic testing giants such as GeneDx provided an option where they delivered clinician ordered genetic tests. Similarly, clinics and healthcare providers along with patients are now using telehealth as a measure to conduct genetic counselling. In addition, prenatal testing remains least affected out of all types of genetic testing as it is highly essential. For instance, many prenatal genetic counselors reported providing face to face services in the pandemic. Thus, pandemic had an overall negative impact on the genetic testing market.
The global genetic testing market is segmented on the basis of type, technology, application, and region. By type, the genetic testing market size is categorized into predictive & presymptomatic testing, carrier testing, prenatal & newborn testing, diagnostic testing, pharmacogenomic testing, and others. On the basis of technology, it is divided into cytogenetic testing/chromosomal analysis, biochemical testing, and molecular testing. Molecular testing is further classified into DNA sequencing and others. By application, it is segmented into cancer diagnosis, genetic disease diagnosis, cardiovascular disease diagnosis, and others. By region, the genetic testing market size is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
By type, the market is segmented into predictive testing & presymptomatic testing, carrier testing, prenatal & newborn testing, diagnostic testing, pharmacogenomic testing, and others. The prenatal & newborn testing segment held dominant position with highest revenue in 2019, and is expected to maintain its dominance during the forecast period. This is attributable to growth in awareness among people regarding healthcare and increase in incidences of mortality rate from genetic diseases across the world. On the other hand, the pharmacogenomic testing segment is anticipated to witness highest CAGR during the forecast period. This is largely anticipated to increase in application in use of personalized medicine across the globe.
Get more information on this report : Request Sample Pages
By technology, the molecular testing segment acquired the major genetic testing market share in the year 2019, and is expected to maintain a lead during the forecast period. The growth of this segment is attributed to the fact that molecular testing is the most used technology for genetic testing. For instance, the technology is used in genetic tests such as carrier testing, diagnostic testing, predictive & presymptomatic testing and others. Furthermore, molecular testing is also preferred as it can be used to analyze gains or losses in DNA that are not detectable with routine chromosome analysis.
Get more information on this report : Request Sample Pages
Region wise, North America was the leading revenue contributor to the global genetic testing market in 2019, and is expected to dominate the market during the forecast period. This is attributed to presence of majority of key players in the region. However, Asia-Pacific is expected to grow at the highest CAGR during the forecast period, owing to increase in affordability, surge in healthcare expenditure, and rise in awareness toward early screening of genetic disorders.
Get more information on this report : Request Sample Pages
The global genetic testing market is highly competitive and the prominent players in the market have adopted various strategies to garner maximum genetic testing market share. These include collaboration, product launch, partnership, and acquisition. Major players operating in the market include Abbott Laboratories, Bio-Rad Laboratories, Inc. (RainDance Technologies, Inc.), Myriad Genetics, Inc. (Myriad RBM, Inc.), Danaher Corporation (Cepheid), F. Hoffmann-La Roche Ltd., Eurofins Scientific, Illumina, Inc., Qiagen N.V., Thermo Fisher Scientific, Inc., and CSL Ltd.
Key Benefits For Stakeholders
Key Market Segments & Key Market Players
Segments | Sub-segments |
---|---|
BY TYPE |
|
BY TECHNOLOGY |
|
BY APPLICATION |
|
BY REGION |
|
Key Market Players |
|
Loading Table Of Content...
In accordance with several interviews conducted, applications of genetic testing are anticipated to witness a significant rise with technological advancements, rise in prevalence of genetic diseases, and increase in awareness & acceptance of personalized medicines. As per CXOs, increase in economic strength of developing nations such as Japan, China, India, Indonesia, and Thailand as well as rise in healthcare expenditure are expected to drive the market growth during the forecast period.
Rapid growth was observed in adoption of advanced technology in the healthcare industry across developing economies, and this is expected to offset challenging conditions in mature markets such as North America and Europe. Moreover, Asia-Pacific is expected to grow at the highest CAGR during the forecast period, owing to increase in affordability, surge in healthcare expenditure, and rise in awareness toward early screening of genetic disorders.
A. The total market value of genetic testing market is $12,682 million in 2019.
A. The forecast period for genetic testing market is 2020 to 2027
A. The market value of genetic testing market in 2019 is $10,866 million.
A. The base year is 2019 in genetic testing market
A. Top companies such as, Thermo Fisher Scientific, Inc., Illumina, Inc., F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., Qiagen N.V., and Myriad Genetics, Inc. held a high market position in 2019. These key players held a high market postion owing to the strong geographical foothold in different regions.
A. Prenatal and newborn testing segment is the most influencing segment as newborn testing is very vital and the awareness related to it is on a rise across the globe. In addition, people are also becoming aware about the importance of prenatal testing which leads to surge in demand for prenatal testing across the globe.
A. The major factor that fuels the growth of the global genetic testing market includes increase in incidences of genetic disorders and cancer which leads to surge in demand for genetic testing.
A. Asia-Pacific has the highest growth rate in the market which is growing due to the contribution of the following emerging countries such as China with a CAGR of 14.5%. This is due to increase in healthcare expenditure and technological advancements, with respect to genetic testing.
A. Genetic testing is the study of DNA that identifies gene mutation associated with a variety of genetic disorders.
A. Genetic testing plays a vital role in determining the risk of developing certain diseases as well as screening and sometimes medical treatment.
Start reading instantly.
This Report and over 13,000+ more Reports, Available with Avenue Library. T&C*.
10%
Discount
10%
Discount
15%
Discount
15%
Discount
Enterprise
License/PDF
20%
Discount
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers